China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of Risk Factors for Seizures and Their Correlation with Prognosis in Patients with Anti-NMDAR Encephalitis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130228
Registration Time: 2026/08/17
Type: Observational study
Primary Sponsor: The First Hospital of Jilin University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331451
Published by HT Digital Content Services with permission from Health Daily Digest....